Loading

American Society of Radiologic Technologists Approves Sensus Healthcare’s SRT Systems for Continuing Education Units

American Society of Radiologic Technologists Approves Sensus Healthcare’s SRT Systems for Continuing Education Units

Beginning September 1, Category A credits will be available for in-person trainings on the SRT-100™, SRT-100+™ and SRT-100 Vision™ systems

BOCA RATON, Fla. (August 5, 2020) – Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, and the leading provider of superficial radiotherapy (SRT), reports that the American Society of Radiologic Technologists (ASRT) has approved Sensus Healthcare’s SRT Systems for Continuing Education Units (CEUs). The approval covers all three SRT systems offered by Sensus, namely the SRT-100™, the SRT-100+™ and the SRT-100 Vision™, and automatically recognizes Sensus Healthcare training as a legitimate provider for CEUs.

The ASRT approval provides radiation therapists Category A credits, with 4.5 CEUs for the SRT-100 and SRT 100+, and 6.5 CEUs for the SRT-100 Vision in-person clinical trainings beginning September 1, 2020.  Now that the ASRT has recognized the Company’s training with CEUs, the American Registry of Radiologic Technologists (ARRT) automatically recognizes Sensus Healthcare training as a legitimate provider for CEUs.  The ARRT requires Registered Technologists to complete and report 24 credits of approved continuing education activities every two years to maintain their registration.

“This determination by the ASRT complements existing support by the radiotherapeutic community for SRT, and follows last month’s American Society for Radiation Oncology’s recommendation of SRT as the first-line alternative to surgery when treating patients with non-melanoma skin cancer,” said Joe Sardano, chairman and chief executive officer of Sensus Healthcare.  “By recognizing Sensus as a provider for CEUs, our SRT systems can now enjoy further validation of the importance of SRT for the treatment of non-melanoma skin cancer.”

“We’re so excited to offer radiation therapists who undergo our comprehensive clinical training the ability to earn clinical education hours through the ASRT.  This recognition by such a notable national association adds further legitimacy to the role of radiation therapists administering superficial radiation treatments for our users,” added Monica DiGioia, director of clinical applications of Sensus Healthcare.

Share to:

Contact Us

Fill out the form below to find out more!